Pharmaceutical R&D policy in Mexico

• In: Comparing Healthcare Systems (Administrative Pharmacy Section) on Tuesday, 7 September 2004, 9:00-17:00
• At: New Orleans (USA) (2004)
• Type: Presentation
• By: KRAVZOV, Jaime (UAM-Xochimilco, Sistemas Biológicos, Mexico Df, Mexico)
• Co-author(s): Altagracia-Martínez, Marina (UAM-Xochimilco, Mexico DF, Mexico)
  López-Naranjo (UAM-Xochimilco, Mexico DF, Mexico)
  
• Abstract:

  The World Development Report estimated that developing countries account for almost 90% of the global burden of disease. A significant share of burden is from conditions such as malaria and tuberculosis that primarily occur in our countries. Of the $30 billion dollars spent on health research only 5% went to health problems unique to developing

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login